Nwachukwu E. William

ORCID, self-asserted

ORCID 0000-0001-7111-1320

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

18 works in the graph, newest first.

Seroprevalence and Risk Factors for Taenia solium Cysticercosis and Taeniasis among Children in Nigeria, 2018
2026American Journal of Tropical Medicine and HygieneJournalOpen access0 citations10.4269/ajtmh.25-0194
A systematic narrative review of risk drivers of yellow fever reemergence in Africa from 1974 to 2025
2026Discover Public HealthJournalOpen access1 citations10.1186/s12982-026-01939-6
Field validation and application of the luminex triplex HIV assay to estimate HIV prevalence and HIV-1 incidence in Nigeria
2025PLOS Global Public HealthJournalOpen access0 citations10.1371/journal.pgph.0003455
Nationwide surveillance detects yellow fever and chikungunya viruses in multiple Aedes mosquito species in Nigeria
2025Parasites & VectorsJournalOpen access4 citations10.1186/s13071-025-07051-z
Epidemiology of Yellow Fever in Nigeria: Analysis of Climatic, Ecological, Socio-Demographic, and Clinical Factors Associated with Viral Positivity Among Suspected Cases Using National Surveillance Data, 2017–2023
2025Journal of Epidemiology and Global HealthJournalOpen access2 citations10.1007/s44197-025-00341-w
Response Rates in a COVID-19 Seroepidemiological Survey in Nigeria: Variations by State, Age Group, and Urban-Rural Settings
2025Science Journal of Public HealthJournalOpen access0 citations10.11648/j.sjph.20251301.11
Epidemiology of Yellow fever in Nigeria: Analysis of climatic, ecological, socio-demographic, and clinical factors associated with viral positivity among suspected cases using national surveillance data, 2017-2023
2025Journal of Interventional Epidemiology and Public HealthJournalOpen access0 citations10.37432/jieph-confpro5-00201
Socio-demographic, climatic, ecological and clinical predictors of Lassa fever virus positivity in Nigeria: Analysis of multi-year national surveillance data, 2018-2021
2025Journal of Interventional Epidemiology and Public HealthJournalOpen access0 citations10.37432/jieph-confpro5-00240
Lessons learnt from laboratory capacity building in supporting integrated disease serosurveillance using a multiplex bead assay in Nigeria
2025African Journal of Laboratory MedicineJournalOpen access0 citations10.4102/ajlm.v14i1.2861
Seroprevalence and Risk Factors for Toxoplasma gondii Infection in Women of Reproductive Age in Nigeria in 2018
2024American Journal of Tropical Medicine and HygieneJournalOpen access2 citations10.4269/ajtmh.24-0107
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coinfection with Malaria in Selected States in Nigeria
2024Advances in Infectious DiseasesJournalOpen access0 citations10.4236/aid.2024.142031
Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria
2023Journal of Clinical Virology PlusJournalOpen access5 citations10.1016/j.jcvp.2023.100139
Schistosomiasis Seroprevalence among Children Aged 0–14 Years in Nigeria, 2018
2023American Journal of Tropical Medicine and HygieneJournalOpen access4 citations10.4269/ajtmh.23-0219
Treponemal Antibody Seroprevalence Using a Multiplex Bead Assay from Samples Collected during the 2018 Nigeria HIV/AIDS Indicator and Impact Survey: Searching for Yaws in Nigeria
2023American Journal of Tropical Medicine and HygieneJournalOpen access0 citations10.4269/ajtmh.22-0670
Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey
2022PLOS Global Public HealthJournalOpen access22 citations10.1371/journal.pgph.0000363
Metagenomic sequencing characterizes a wide diversity of viruses in field mosquito samples in Nigeria
2022Scientific ReportsJournalOpen access27 citations10.1038/s41598-022-11797-2
COVID-19 mortality rate and its associated factors during the first and second waves in Nigeria
2022PLOS Global Public HealthJournalOpen access12 citations10.1371/journal.pgph.0000169
COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?
2022Journal of Global HealthJournalOpen access1 citations10.7189/jogh.12.03055